Summary Human foetal keratinocytes were transfected with a recombinant plasmid (pSV6-1) which contained an origin defective SV40 genome. The resulting transformed cell line had many properties in common with previously described SV40-transformed keratinocytes, including expression of simple epithelialtype keratins. It was non-tumourigenic in nude mice at early passages, forming small benign cysts, however, after approximately 46 in vitro passages, these transformed keratinocytes formed invasive squamous cell carcinomas in athymic nude mice. Several in vitro changes were associated with this acquisition of tumourigenicity (a) an alteration in cellular morphology, (b) development of a cytogenetically marked clone and (c) loss of cell surface fibronectin. The loss of fibronectin was also observed in vivo; cysts formed by SV6-1 Bam/HFK produced human fibronectin whereas tumours did not, although both tumours and cysts were laminin-and keratin-positive. These results indicate that the spontaneous development of secondary events in immortalised human cells may lead to the acquisition of a malignant phenotype.
Transformation of cells in vitro has for many years been used as a model system to define the steps involved in malignant transformation in vivo. In vitro transformation has the advantage of allowing the effects of purified transforming genes to be studied using defined target cells. Such systems have, for instance, defined distinct classes of cooperatively acting oncogenes (Land et al., 1983; Ruley, 1983) . Rodent fibroblasts have been used in most of these studies, but more recently human epithelial cells (from which most human cancers arise) have been utilized. Transformation of human epithelial cells has recently been reviewed by Chang (1986) .
The human epidermal keratinocyte system has become one of the most important in vitro epithelial cell systems for the study of cellular transformation, since their cultivation was first reported by Rheinwald and Green (1975) . In 1979, Steinberg and Defendi showed that human epidermal keratinocytes cultured by these methods could be transformed by Simian virus 40 (SV40) (Steinberg & Defendi, 1979) . Since that date there have been several investigations on the in vitro effects of SV40 on human keratinocytes (Taylor-Papadimitriou et al., 1982; BanksSchlegel & Howley, 1983; Rhim et al., 1985) . SV40 has been shown to immortalise keratinocytes, to impair their ability to follow the normal pathway to terminal differentiation, to alter their response to tumour promoters, to decrease their growth requirements in vitro and to induce several other phenotypic alterations, including changes in keratin profiles, the actin cytoskeleton and the extracellular matrix (Steinberg & Defendi, 1979 , 1985 Taylor-Papadimitriou et al., 1982; Banks-Schlegel & Howley, 1983; Rhim et al., 1985; Parkinson et al., 1983 Parkinson et al., , 1984 Hronis et al., 1984; Bernard et al., 1985; Brown & Parkinson, 1984; Edelman et al., 1985; Defendi et al., 1982) .
Many of these changes produce a phenotype which is similar to that expressed in vitro by keratinocytes derived from human squamous cell carcinomas (SCCs) (Parkinson et al., , 1984 Rheinwald & Beckett, 1980 Rupniak et al., 1985; Wu & Rheinwald, 1981; Brown & Parkinson, 1985) . However, SV40 transformed human keratinocyte cell lines have never been shown to be tumourigenic in vivo, without a contribution from either another transforming virus (Rhim et al., 1985) or the mutagenic effects of a chemical carcinogen .
In this paper we describe the establishment and some in Correspondence: P.H. Gallimore. Received 22 April 1987; and in revised form 7 July 1987.
vitro properties of an SV40-transformed human epidermal keratinocyte cell line which undergoes spontaneous progression to a malignant phenotype. Brief descriptions of this line have appeared in some previous papers from this laboratory (Parkinson et al., , 1984 Brown & Parkinson, 1984) .
Materials and methods
Establishment of the cell line Cultures of keratinocytes were derived from a sample of skin from an 18-week old male human foetus, using the methods of Rheinwald and Green (1975) as described previously (Burnett & Gallimore, 1983) . For the production of SV40 transformants, foetal keratinocytes were plated at 2 x lIO cells per 9 cm dish, with 3T3 feeder layers, in Dulbecco's modification of Eagle's medium (DME), supplemented with 20% foetal bovine serum, 0.4 pg ml-1 hydrocortisone and 10 ng ml-1 cholera toxin.
When colonies had reached 4-8 cells in size, the 3T3 feeder layers were removed with EDTA (Rheinwald & Green, 1975) and the keratinocytes were transfected (Graham & van der Eb, 1973) with Bam-HI linearised pSV6-1 DNA, an origindefective mutant of SV40 (Gluzman et al., 1980) . After transfection, fresh 3T3 feeder cells were added back. Rapidly growing foci of compact epithelioid cells appeared in transfected cultures, and were picked 4 weeks post-transfection. These cells were then cultured in Joklik's medium, supplemented with 10% foetal bovine serum, hydrocortisone and cholera toxin. 3T3 feeder layers were used for the first subculture but were unnecessary for subsequent subcultures and in later passages hydrocortisone and cholera toxin could be omitted. Subculturing was performed with trypsin-EDTA at a split ratio of 1:3 for the first three passages and at 1:20 thereafter.
Tumourigenicity studies Athymic (nude) mice were inoculated s.c. with 107 cells. For histology, excised tumours or cysts were fixed in formaldehyde/acetic acid/methanol (1:1:8 by vol.), embedded in paraffin, sectioned and stained in haematoxylin and eosin (H&E). For immunofluorescence, excised tumours were snap frozen in liquid nitrogen, embedded in 'Tissue-tek' (Miles Laboratories, Illinois, USA) and then 5 Hm cyrostat sections were cut and picked up onto gelatin-coated slides, fixed in acetone and air-dried.
For culturing tumour cells, the tissue was minced with D The Macmillan Press Ltd., 1987 Br. J. Cancer (1987 546 K.W. BROWN & P.H. GALLIMORE scissors, digested in trypsin-EDTA and the cells were plated out onto a 3T3 feeder layer (to inhibit the growth of mouse fibroblasts) in Joklik's medium. Feeder layers were not used in subsequent subcultures.
Cytogenetics
Metaphase preparations were made as previously described (Gallimore & Richardson, 1973) (Geiger & Bessman, 1972) were electrophoresed on 7.5% SDS-polyacrylamide gels (Laemmli, 1970) . Gels were stained in Coomassie blue and then electrophoretically transferred to nitrocellulose sheets as described by Jackson and Thompson (1984) . The nitrocellulose filters were next soaked for 1 h at 37°C in 3% (w/v) bovine serum albumin (BSA) in PBS, rinsed in PBS containing 0.1% (v/v) Tween 20 and then incubated for 1 h at 37°C in a 1 in 100 dilution of AE1 or AE3 monoclonal antibody supernatant (WoodcockMitchell et al., 1982) , diluted in 3% BSA in PBS. The monoclonal anti-keratin antibodies were a kind gift from Dr T-T. Sun Primary antisera used were as follows: SV40 T-antigen; serum from a rat carrying an SV40-induced tumour, keratin; rabbit antiserum to human callous keratins (prepared by Dr E.K. Parkinson and P.H. Gallimore in this department, exactly as described by Sun and Green (1978) ), fibronectin; sheep antiserum to human plasma fibronectin (Serotec), fibronectin, human; mouse monoclonal antibody to human fibronectin (IST2; see Zardi et al., 1980) 
Results
Establishment of the cell line Transfection of human foetal keratinocytes with DNA from the origin-defective SV40 mutant pSV6-1 (Gluzman et al., 1980) produced foci (4-10 transformants for 10,ug pSV6-1 per dish) of rapidly growing, morphologically altered keratinocytes. One such focus was picked and designated SV6-1 Bam/HFK. These cells established into a permanent, apparently immortal cell line, without any noticeable crisis phase; although terminal differentiation was observed in colonies at early passages. The cell line has been continuously subcultured for at least 212 passages (-916 population doublings); this is in contrast to the limited in vitro lifespan (-160 population doublings) of normal human keratinocytes (Rheinwald & Green, 1977) .
SV6-1 Bam/HFK keratinocytes showed far less stringent growth requirements than normal keratinocytes, and after initial early passages they required neither 3T3 feeder layers, hydrocortisone, cholera toxin nor epidermal growth factor for optimal growth.
The cells were all positive for SV40 T-antigen as shown by immunofluorescence ( Figure la ) and SV40 T-antigens were detected in immunoprecipitation and immunoblotting experiments (data not shown).
Morphology of the transformed cells Early passage cultures resembled normal keratinocytes in morphology, although they appeared darker under phase optics than normal keratinocytes and there was little evidence of stratification and differentiation (Figure lb ). At about passage 12 (-60 population doublings) some heterogeneity became apparent in the cultures, with the appearance of smaller more tightly packed cells, and at a low frequency, some short fibroblastic cells. All cell types were SV40 Tantigen positive. The minority fibroblastic cells, could be removed by brief EDTA treatment (Rheinwald & Green, 1975) and this procedure was used to maintain cultures with an epithelial morphology. As the cultures were passaged further, the smaller epithelial cell type began to predominate, so that at high passage levels ( -35-40) the cultures consisted almost entirely of very small, tightly packed cells (Figure ic) , and this homogeneous morphology was maintained at all further passages.
Cytogenetics
Between passage 3 and 20 the cell line was predominantly pseudodiploid, but also contained a high proportion (-40% metaphases) of polyploid cells. At this stage no cytogenetically marked clones were identified, but the majority of cells were cytogenetically abnormal with dicentric and/or ring chromosomes and chromosome translocation and fragments. From this heterogeneous population a cytogenetically marked hyperdiploid clone was evident by passage 47 (Table I) . Three different isochromosomes (markers 1, 3 and 4) were present in each pseudodiploid cell and most cells also contained an acrocentric marker (marker 2) and a small abnormal metacentric marker (marker 5) as illustrated as an insert to Figure 2 . Haploidy for autosomes 7, 11, 15 and 18 and trisomy 3 was evident in most metaphases of the clone. One chromosome 3 was abnormal with a deletion from p22-pter. High quality G-banded Figure 2 ). The inverted chromosome 13, the isochromosome markers 3 and 4, and the small marker 5 were not retained, but 90% of the cells were 3p-, -11, -17, -18 (or if diploid for 18 one autosome had additional material on the q arms) plus markers 1 and 2 (see Table I and Figure 2 ).
Tumourigenicity
At early passages SV6-1 Bam/HFK cells failed to form tumours in athymic (nude) mice. They either formed small disorganised cystic structures ( -5 mm diameter) which regressed after about 7 days, or more usually they produced small keratinized cysts of similar size, which remained on the animals for up to 2 months. Histological examination of such cysts revealed that compared to normal foetal skin epidermis (Figure 3b ) more cell layers were evident, parabasal mitoses were frequently observed, and the cells had irregular shaped nuclei (Figure 3a) . Keratohyalin granules and cornified squames were seen at irregular intervals on the inner aspects of these cysts, but no keratohyalin granules were observed in foetal skin epidermis. (Table I) .
At later passages (greater than 43), SV6-1 Bam/HFK cells produced malignant tumours in 100% of nude mice. Immediately after inoculation a small nodule formed, but after a latent period of -4 weeks, large progressively growing tumours formed which attained a diameter > 1 cm. Histological examination of the tumours revealed groups of tumour cells interspersed with connective tissue and in some areas keratin 'pearls' formed (Figure 3c ), which resembled structures normally seen in human SCCs. At the edges of the tumour it could be clearly seen that invasion was occurring into surrounding mouse tissue e.g. muscle fibres (Figure 3d ) and an adjacent rib (Figure 3e ). Invasion was also observed macroscopically, since in some tumours the mouse epidermis was breached, producing an ulcerated lesion, whilst in others the tumours were found to be firmly attached to the chest wall of the nude mouse, with invasion of intercostal muscles and ribs.
When cells from the nude mouse tumours were reestablished in culture, they had a morphology which was identical to that of the cells used for injection i.e. like that shown in Figure ic . Furthermore their pattern of keratin expression (see below), and karyotype ( Figure 2 and Table I ), closely resembled the high passage cells. On re-inoculation into nude mice these cells were found to be highly tumourigenic with a tumour producing dose100 of less than 104 cells (Table I) .
Keratins
As shown previously by others (Sun & Green, 1978 . ' . . ' . . . . bands did not persist (Figure 4b , lane 7) and the overall keratin pattern resembled that of the high-passage cultured SV6-1 Bam/HFK cells, except that the 50Kd keratin was produced in larger amounts in the tumour cells (Figure 4 , lane 7). The 46 Kd keratin, which was not detected by either AE1 or AE3 antibodies, was produced in all transformed and tumour cells as shown by protein staining (Figure 4a , lanes 4 to 7). Immunofluorescence staining of cysts and tumours In the cysts formed by low passage SV6-1 Bam/HFK keratinocytes, a band of SV40 T-antigen positive cells could be seen (Figure 5a ) which was keratin-positive ( Figure 5b ). These cells were clearly producing human fibronectin, since the same area was stained with the monoclonal antibody IST2 ( Figure Sc) ; this antibody only recognises human, and not mouse fibronectin (Zardi et al., 1980) . The laminin antibody used in these studies was raised against mouse (EHS sarcoma) laminin, but cross-reacts with the human protein (Brown & Parkinson, 1984) . A simple stain with this antisera was therefore insufficient to investigate whether laminin might be being produced by the injected human keratinocytes, and a double-label procedure was therefore used to stain both SV40 T-antigen and laminin on the same section. This technique demonstrated that the T-antigen positive cells in the cyst were closely associated with areas of laminin staining ( Figure Sd, e) .
In the tumours, the double labelling method was used throughout, since all the areas of tumour cells were interspersed with mouse connective tissue. This staining showed that the areas of keratin-positive tissue in the tumour were indeed T-antigen positive SV6-1 Bam/HFK cells (Figure 6a,  b) . These clusters of tumour cells were surrounded by areas of fibronectin-containing tissue (Figure 6c, d ), which must have been mouse in origin, because no areas of the tumour were stained with the monoclonal antibody IST2 (data not shown). The islands of tumour cells were surrounded by an almost continuous basement membrane-like pattern of laminin staining (Figure 6e, f) , but the tumour itself was not
The line went through no apparent 'crisis' period during its establishment; (2) (Parkinson et al., , 1984 , and their altered response to tumour promoters (Parkinson et al., , 1984 ; (4) our SV40 transformed keratinocytes retained the ability to produce extracellular matrix components, and at early passage levels produced increased amounts of fibronectin (Brown & Parkinson, 1984 Hronis et al., 1984; Bernard et al., 1985; Banks-Schlegel & Rhim, 1986) , the expression of keratins normally found in simple epithelia (54Kd and 52Kd; Figure 4 ) was increased in our SV40 transformed keratinocytes, although we could find no significant difference in 40 Kd keratin expression between normal and transformed cells (Figure 4 ). In the tumour, the inntfArn of l-Arntin PsYr%recoinn rAncAvurPeml that nf patternll t)1 litinLl exprC;ssionl usIuiCy rtusmirUC; [LnkL 01 cultured keratinocytes (Figure 4) i.e. the tumour expressed a 'hyperproliferative' keratin pattern, as has been found in encapsulated by a basen specimens examined (da Discussion The SV40 transformed line described in th progression to a malign, unique, we believe, but previously described S (Steinberg & Defendi, al., 1982; Banks-Schlege Hronis et al., 1984; Bei Rhim, 1986 ; Edelman e human SCCs (Weiss et al., 1984) . On re-establishing the tumour cells in vitro, the keratin pattern reverted to one similar to that of cultured SV6-1 Bam/HFK cells, once again emphasising how keratin expression is modulated by the cell's external environment Fuchs & Green, 1981; Doran et al., 1980) . Although some differentiation was evident in the tumour, demonstrated by the production of keratin 'pearls' (Figure 3b ), no 67 Kd keratin (characteristic of fully keratinized epidermis ) was detected. This could have merely reflected the very low level of differentiation as compared to normal epidermis, or alternatively the area of tumour used for human keratin polypeptides. (a) keratin analysis may have been particularly undifferentiated.
SDS-polyacrylamide gel of keratin
Two novel AEl positive keratin bands (45 Kd and 55 Kd) ot stained with AEI monoclonal antiwere detected in the tumour, but not in any of the cultured nunoblot stained with AE3 monoclonal. cells (Figure 4 ). lane 2, cultured adult keratinocytes; lane
In this paper we have extended our previous in vitro ocytes; lane 4, SV6-1 Bam/HFK cells at (Brown & Parkinson, 1984) In and Green (1978) . Dots in (b), lane 6, amounts of mouse fibronectin (Figure 6d ). Thus the 45 Kd AEI-positive keratins. reduction in fibronectin production which occurs as SV6-1 Bam/HFK keratinocytes are passaged in vitro (Brown & Parkinson, 1984 Gusterson et al. (1984) for human SCCs. keratinocytes formed malignant tumours when inoculated into athymic (nude) mice. Similarly, it has been reported that many SV40 transformed rodent cells require extensive passaging before they become tumourigenic (Tevethia, 1980) . Several in vitro phenotypic changes were associated with the development of malignant potential in SV6-1 Bam/HFK: (1) An alteration in cellular morphology ( Figure 1) ; (2) Development of a cytogenetically marked stem cell line (Table I) ; and (3) A reduction in fibronectin production (Brown & Parkinson, 1984) . These alterations could be explained by the development of an altered subpopulation of transformants with a selective growth advantage, which eventually outgrew the non-malignant transformants.
Whether any of these changes in in vitro phenotype were a cause or a consequence of the development of malignancy, they clearly indicate that a second event (or more) had occurred after the initial establishment of the cell line. This second event could possibly have been a re-arrangement of integrated viral sequences, although the lack of an origin of replication in the SV6-1 DNA used (Gluzman et al., 1980) means that the integrated viral sequences would be unable to undergo any T-antigen directed replication that could promote excision and re-integration of viral DNA. Indeed Southern blotting data (Byrd & Gallimore, unpublished data) have shown no major differences in the pattern of integrated SV40 sequences between low-and high-passage SV6-1 Bam/HFK cells (and additionally this confirms that the squamous cell carcinomas were produced by SV6-1 Bam/HFK cells).
Other likely candidates for possible second events are the activation of cellular proto-oncogenes and/or loss of gene products capable of malignancy suppression. In particular ras oncogenes have been implicated in the development of epidermal malignancies (reviewed in Balmain, 1985) and infection of mouse keratinocytes with ras-containing retroviruses has been shown to induce alterations in their differentiation programme and growth factor requirements (Yuspa et al., 1985; Weissman & Aaronson, 1985) . In addition Rhim et al. (1985) have recently demonstrated that human keratinocytes immortalized with an adenovirus 12-SV40 hybrid virus could then be converted to a malignant phenotype by addition of Kirsten murine sarcoma virus, a ras-containing virus. However, Rhim et al. (1986) to suggest ras activation. We are now investigating whether there is any evidence of ras gene activation in high passage SV6-1 Bam/HFK cells. Spontaneous activation of the N-ras proto-oncogene has been previously demonstrated following in vitro cultivation of a human teratocarcinoma cell line (Tainsky et al., 1984) .
Previous reports have indicated that other SV40 transformed human keratinocytes are non-tumourigenic (Chang, 1986; Banks-Schlegel & Howley, 1983; Hronis et al., 1984) , even though some have been shown to form short-lived cysts which resembled human SCCs (Banks-Schlegel & Howley, 1983) . The development of malignancy in the SV6-1 Bam/HFK line required extensive in vitro passaging, and one possibility is that other SV40 transformants have simply not been passaged sufficiently to accumulate secondary events necessary to produce malignancy. The difference in our line is probably not due to the use of foetal keratinocytes since, from a number of independently derived SV40 transformed human keratinocyte cell lines from post-neonatal donors with an inherited susceptibility to cancer, two eventually acquired a malignant phenotype on passage (Gallimore, Stacey & Taylor, unpublished data) .
The evolution of a cytogenetically marked clonal population was clearly a major feature of the progression of SV6-1 Bam/HFK cells. Of the five marker chromosomes identified in the high passage clone only markers 1 and 2 were retained in the nude mouse derived SCC lines. Although we have been unable to identify unequivocally the origins of these markers their retention in the tumours may indicate that genes mapping on these abnormal markers made a contribution to the genesis of a malignant phenotype. In addition, the cytogenetic changes to autosomes 3 and 11 may also be of significance. A number of human tumours have been shown to have deletions or re-arrangements of the p arms of chromosome 3 similar to SV6-1 Bam/HFK (Figure  2 ), including tumours of epithelial origin (Yoshida et al., 1985) . Interestingly, Teysseir et al. (1986) recently showed that in two renal cell carcinomas the deletion of 3p resulted MALIGNANT PROGRESSION OF HUMAN CELLS IN VITRO 553 in the interstial translocation of the proto-oncogene c-raf 1 from 3p 25 to 3p 14. At least two proto-oncogenes, c-Ha-ras 1 (llp 15, de Martinville & Franke, 1983) and c-ets ( llq 23-24 De Taisne et al., 1984) have been mapped to chromosome 11, as has the locus associated with Wilm's tumour (lip 13, Koufos et al., 1984) . Genetic change to the single copy of chromosome 11 in the high passage SV6-1 Bam/HFK clone at any of these genetic loci may have generated the malignant phenotype. Saxon et al. (1986) have recently shown that chromosome 11 can suppress the malignant phenotype of HeLa cells. Clearly the possible involvement of the loss of one copy of autosome 11 in the malignant phenotype of SV6-1 Bam/HFK cell could be resolved by the development of somatic cell hybrids between the fibroblast hybrid ESH15(TI) and SV6-1 Bam/HFK SCC, in an analogous manner to Saxon et al.
The results described in this paper, together with a previous report (Tainsky et al., 1984) indicate that profound genetic changes may occur spontaneously during the in vitro cultivation of human cells, and therefore caution is indicated in interpreting the results from so-called '2-stage' in vitro models where multiple genes or agents have been used, since conversion of SV6-1 transformed normal keratinocytes to a malignant phenotype may have represented several spontaneous events.
